What’s the deal? Arintra, a Texas-headquartered startup with a base in Bengaluru, has raised about $25 million in a Series B round led by US healthcare venture firm Define Ventures. Existing backers Y Combinator, Ten13 Capital, Counterpart Ventures, and Spider Capital joined, alongside new investors Yale New Haven Ventures and Endeavor Ventures. Peak XV Partners, which led Arintra’s earlier $21 million Series A, also participated.
What does it do? Founded by Preeti Bhargava and Nitesh Shroff, Arintra runs an autonomous medical coding platform for healthcare providers. Its GenAI-native system combines large language models with clinical knowledge graphs to read patient charts in context and apply specialty-specific coding rules.
How it works: The platform integrates with electronic health record systems such as Epic and Athena to automate medical coding — the process of turning clinical documentation into standardised codes used for billing, reimbursement, and reporting. The company is likely to raise a small additional amount as part of the ongoing round.
Why it matters: The round ranks around the 65th percentile by size — a solid but not outsized raise in the current market. It reflects Peak XV’s growing appetite for US AI and enterprise startups since its 2023 split from Sequoia Capital.
Zoom out: Peak XV has been busy beyond India. In August 2026 it joined AI voice startup Wispr Flow’s $280 million Series B, and it joined a $50 million round in voice AI startup Vapi. Its healthcare bets include AI revenue platform Claim Health.
The signal: Arintra sits at the intersection of two hot themes — generative AI and healthcare administration, where labour-intensive coding is a persistent cost. For Peak XV, the follow-on investment underscores a deliberate pivot toward US-based AI infrastructure and applied software as it builds a global portfolio.
Read more: VC Circle
Image credit: Generated with Gemini
